Literature DB >> 22171077

Disorder gene expression of extracellular matrix and adhesion molecules in saphenous vein conduits of diabetic patients.

Yongxin Sun1, Wenjun Ding, Qiang Wei, Wang Chun Sheng.   

Abstract

Saphenous vein (SV) is the most commonly employed conduit in coronary surgery. However, the extracellular matrix (ECM) characteristics of SV in diabetic patients still remain unclear. This study was to survey the ECM gene expression profile of SV in diabetic patients. Thirty-five patients had type 2 diabetic mellitus; the non-diabetic (control) group comprised 49 patients. The expression profile of ECM genes was analysed by microarray. Tissue MMP/TIMP protein activities were evaluated by immunocytochemistry and western-blot. In this microarray, 25 genes demonstrated at least a 3-fold difference in expression. Upregulation was observed in 20 genes, while five genes appeared to be downregulated. SV exposed to DM conditions demonstrated a notable increase in MMP-2 and MMP-9 but a significant decrease in TIMP-2 and TIMP-3 in protein concentration compared with control group. This study suggests that native ECM gene expression profile of SV in diabetic patients has showed signs of the vein graft disease process before coronary surgery. Preoperative profiles of diabetic patients might provide some useful clues regarding vein graft quality and prompt adjustment in surgical strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22171077      PMCID: PMC3290373          DOI: 10.1093/icvts/ivr053

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  11 in total

1.  Mechanical properties of native and ex vivo remodeled porcine saphenous veins.

Authors:  Rebecca J Gusic; Matus Petko; Richard Myung; J William Gaynor; Keith J Gooch
Journal:  J Biomech       Date:  2005-09       Impact factor: 2.712

2.  Saphenous neuralgia after coronary artery bypass grafting.

Authors:  J Mountney; G A Wilkinson
Journal:  Eur J Cardiothorac Surg       Date:  1999-10       Impact factor: 4.191

3.  Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI).

Authors:  Leonard Schwartz; Kevin E Kip; Robert L Frye; Edwin L Alderman; Hartzell V Schaff; Katherine M Detre
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

4.  Association of albuminuria and reduced estimated glomerular filtration rate with incident stroke and coronary artery disease in patients with type 2 diabetes.

Authors:  Ryotaro Bouchi; Tetsuya Babazono; Naoshi Yoshida; Izumi Nyumura; Kiwako Toya; Toshihide Hayashi; Ko Hanai; Nobue Tanaka; Akiko Ishii; Yasuhiko Iwamoto
Journal:  Hypertens Res       Date:  2010-09-30       Impact factor: 3.872

Review 5.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

6.  Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits.

Authors:  Mark P Anstadt; Dion L Franga; Vera Portik-Dobos; Arjun Pennathur; Mary Bannan; Kwabena Mawulawde; Adviye Ergul
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

7.  Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells.

Authors:  Neil A Turner; Selina Ho; Philip Warburton; David J O'Regan; Karen E Porter
Journal:  J Vasc Surg       Date:  2007-05       Impact factor: 4.268

8.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

9.  Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

Authors:  Prabhakara Reddy Nagareddy; Hesham Soliman; Guorong Lin; Padmesh S Rajput; Ujendra Kumar; John H McNeill; Kathleen M MacLeod
Journal:  Diabetes       Date:  2009-07-08       Impact factor: 9.461

10.  Extracellular matrix retention of thrombospondin 1 is controlled by its conserved C-terminal region.

Authors:  Josephine C Adams; Amber A Bentley; Marc Kvansakul; Deborah Hatherley; Erhard Hohenester
Journal:  J Cell Sci       Date:  2008-02-19       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.